Back
Panbela Therapeutics Vs. Fate Therapeutics Industry Stock Comparison
Sell
16
PBLA
Panbela Therapeutics
Last Price:
0.47
Seasonality Move:
-4.94%
Buy
51
FATE
Fate Therapeutics
Last Price:
3.86
Seasonality Move:
9.33%
Sell
16
Panbela Therapeutics (PBLA)
is a Sell
Is Panbela Therapeutics a Buy, Sell or Hold?
- The current Panbela Therapeutics [PBLA] share price is $0.40. The Score for PBLA is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- PBLA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
51
Fate Therapeutics (FATE)
is a Buy
Is Fate Therapeutics a Buy, Sell or Hold?
- The current Fate Therapeutics [FATE] share price is $3.91. The Score for FATE is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- FATE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PBLA Stock Price Chart
What is Panbela Therapeutics's stock price today?
-
The Panbela Therapeutics share price today is $0.40
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PBLA is experiencing selling pressure, which indicates risk of future bearish movement.
FATE Stock Price Chart
What is Fate Therapeutics's stock price today?
-
The Fate Therapeutics share price today is $3.91
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FATE is experiencing slight buying pressure.
PBLA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 40.99 | Sell |
| Chaikin Money Flow: | -48335 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.39 - 0.47) | Sell |
| Bollinger Bands (100): | (-1.98 - 7.92) | Sell |
FATE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.41 | Sell |
| Relative Strength Index (14 RSI): | 34.58 | Sell |
| Chaikin Money Flow: | 93703 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.81 - 4.71) | Sell |
| Bollinger Bands (100): | (4.25 - 7.09) | Sell |
PBLA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.42 | Sell |
| 20-day SMA: | 0.41 | Sell |
| 50-day SMA: | 0.52 | Sell |
| 200-day SMA: | 11.87 | Sell |
| 8-day EMA: | 0.42 | Sell |
| 20-day EMA: | 0.44 | Sell |
| 50-day EMA: | 1.07 | Sell |
| 200-day EMA: | 647.44 | Sell |
FATE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.07 | Sell |
| 20-day SMA: | 4.06 | Sell |
| 50-day SMA: | 5.6 | Sell |
| 200-day SMA: | 4.05 | Sell |
| 8-day EMA: | 4.04 | Sell |
| 20-day EMA: | 4.31 | Sell |
| 50-day EMA: | 5.03 | Sell |
| 200-day EMA: | 5.51 | Sell |
Panbela Therapeutics Earnings Growth & PBLA Earnings Dates
- Analysts estimate an earnings increase this quarter of $39.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $2,220.22 per share, and an increase next year of $3.68 per share.
Fate Therapeutics Earnings Growth & FATE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.13 per share, and an increase next year of $0.07 per share.
Panbela Therapeutics Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Fate Therapeutics Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||